Coherus BioSciences Archives | Page 2 of 2 | Be Korea-savvy
Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12

Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12

REDWOOD CITY, Calif., Dec. 8 (Korea Bizwire) – Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical biologics platform company focused on the global biosimilar market, today announced that it will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015, at 9:30 a.m. PT at the Westin St. Francis Hotel in San Francisco, [...]

Coherus BioSciences to Host Earnings Conference Call on December 15

Coherus BioSciences to Host Earnings Conference Call on December 15

REDWOOD CITY, Calif., Dec. 4 (Korea Bizwire) — Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical biologics platform company focused on the global biosimilar market, today announced that it has scheduled a conference call for Monday, December 15, 2014, at 1:30 p.m. PT / 4:30 p.m. ET to discuss its third quarter 2014 financial results and [...]

Coherus BioSciences Announces Closing of Initial Public Offering and Exercise of Underwriters’ Option to Purchase Additional Shares

Coherus BioSciences Announces Closing of Initial Public Offering and Exercise of Underwriters’ Option to Purchase Additional Shares

REDWOOD CITY, Calif., Nov. 12 (Korea Bizwire) – Coherus BioSciences, Inc. announced today the closing of its initial public offering of 6,803,702 shares of its common stock at a public offering price of $13.50 per share, before underwriting discounts, commissions and estimated expenses, which includes the purchase of 507,402 shares of Coherus common stock by the [...]

Coherus BioSciences Prices Initial Public Offering of $85 Million of Common Stock

Coherus BioSciences Prices Initial Public Offering of $85 Million of Common Stock

REDWOOD CITY, Calif., Nov. 6 (Korea Bizwire) — Coherus BioSciences, Inc. (Nasdaq:CHRS) announced today the pricing of its initial public offering of 6,296,300 shares of its common stock at a public offering price of $13.50 per share, before underwriting discounts, commissions and estimated expenses. All of the shares of common stock are being offered by [...]